Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

BUY
$137.6 - $154.97 $784,320 - $883,329
5,700 New
5,700 $883,000
Q2 2022

Aug 11, 2022

SELL
$137.62 - $174.96 $275,240 - $349,920
-2,000 Reduced 33.33%
4,000 $613,000
Q4 2021

Feb 07, 2022

BUY
$107.43 - $135.93 $644,580 - $815,580
6,000 New
6,000 $812,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Monetta Financial Services Inc Portfolio

Follow Monetta Financial Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monetta Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Monetta Financial Services Inc with notifications on news.